Akebia Therapeutics (AKBA) Net Long-Term Debt Issued (Repaid) (2014 - 2025)
Akebia Therapeutics' Non-Current Debt was $24.75 million in Q2 2026, down 47.4% from $47.06 million a year earlier and down 32.0% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Net Long-Term Debt Issued (Repaid) (2014 - 2025) Analysis & Trends
At the end of FY2025, Non-Current Debt at Akebia Therapeutics came in at $48.25 million, up 24.7% from FY2024.
- Non-Current Debt shows a five-year compound annual growth rate of -12.9% (FY2020 to FY2025).
- In earlier years, Non-Current Debt was $38.69 million in FY2024 (+125.2%), $17.18 million in FY2023 (-49.6%) and $34.08 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Non-Current Debt since Q4 2023.
- Compared with a year earlier, Non-Current Debt was higher in six of the last eight quarters, with growth averaging 24.2%.
- The best year-over-year quarter for Non-Current Debt over five years was Q4 2024 (growth of 125.2%); the worst was Q4 2023 (a decline of 49.6%).
- Per Business Quant data, AKBA's Non-Current Debt in the three quarters before Q2 2026 was $36.4 million (Q1 2026), $48.25 million (Q4 2025) and $47.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.91 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 9.54 Mn |
| Dec 31, 2024 | 1,000.00 |
| Jun 30, 2024 | 7.63 Mn |
| Mar 31, 2024 | 274,000.00 |
| Dec 31, 2023 | -8.00 Mn |
| Jun 30, 2023 | -8.00 Mn |
| Mar 31, 2023 | -16.00 Mn |
| Dec 31, 2022 | 66.00 Mn |
| Sep 30, 2022 | -33.00 Mn |
| Mar 31, 2019 | 15.00 Mn |
| Dec 31, 2018 | -6,000.00 |
| Sep 30, 2018 | -7,000.00 |
| Jun 30, 2018 | -5,000.00 |
| Mar 31, 2018 | -1,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Sep 30, 2017 | -1,000.00 |
| Jun 30, 2017 | -1,000.00 |
| Mar 31, 2017 | -2,000.00 |
| Dec 31, 2016 | -1,000.00 |
| Sep 30, 2016 | -13,000.00 |
API Access
Akebia Therapeutics Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();